United Natural Foods, Inc. (NYSE: UNFI), a leader in the food distribution industry, has recently announced a significant update to its selling show schedule for 2024. This announcement marks a pivotal shift in how UNFI will be conducting its renowned selling shows, aligning more closely with evolving customer buying behaviors and the diverse needs of suppliers.

UNFI’s 2024 Selling Show Schedule: A New Approach
UNFI is renowned for its commitment to helping customers and suppliers thrive in the competitive marketplace. In 2024, UNFI is taking this commitment a step further by restructuring its selling shows. Unlike previous years where the focus was either on natural and organic or conventional products, the 2024 shows will encompass the full spectrum of products and services. This inclusive approach is designed to cater to both natural and conventional suppliers, as well as all grocery retail customer channels, ensuring a comprehensive market positioning.

Sandy Douglas, UNFI’s Chief Executive Officer, expressed enthusiasm for the upcoming selling show season, emphasizing the importance of connecting with partners, sharing insights, discussing industry trends, and exploring new avenues for creating value and driving growth. Douglas highlighted UNFI’s dedication to supporting suppliers and customers through supply chain efficiency, a wide selection of products, and leading market insights and services.

The Exciting Line-Up for 2024
UNFI has scheduled four major selling shows for 2024:

Spring and Summer West Selling Show in San Diego, CA on February 7-8
Spring and Summer Central and East Selling Show in Orlando, FL on February 20-21
Holiday and Winter East Selling Show in Uncasville, CT on June 4-5
Holiday and Winter Central and West Selling Show in Minneapolis, MN on August 6-7
For more details on these events, interested customers or suppliers can visit UNFI Shows and Events or reach out via email at events@unfi.com.

Introducing the Circle of Excellence Awards
In addition to the revamped show schedule, UNFI is excited to announce its inaugural Circle of Excellence (COE) awards. These awards are set to recognize the exceptional performance and growth of UNFI customers and suppliers. The COE awards will honor innovation, diversity in market positioning, and the geographical spread of customers and suppliers across the nation.

The awards will be segmented into various categories, with customer awards being presented at the February shows in San Diego and Orlando, and supplier awards at the June show in Connecticut. Winners will enjoy recognition across UNFI’s selling shows, feature on UNFI’s website, and mentions in post-show press releases.

UNFI’s updated selling show schedule and the introduction of the Circle of Excellence awards in 2024 represent a significant step forward in the company’s mission to support and celebrate the success of its partners. By adapting to market trends and customer needs, UNFI continues to solidify its position as a leader in the food distribution industry. Stay tuned for more updates and exciting developments from UNFI.

In the bustling neighbourhood of Leslieville in Toronto, a small yet mighty player, Raise the Root, is redefining the landscape of grocery shopping, posing a significant challenge to premium national grocers like Loblaws. This independent grocery store has become a beacon of affordability and community spirit, showcasing how local businesses can stand toe-to-toe with industry giants.

The Innovative Pricing Strategy of Raise the Root

Raise the Root’s unique approach to pricing, which they proudly displayed on their Instagram page, is a game-changer in the grocery industry. By directly comparing their produce prices with those of Loblaws, they have demonstrated that quality groceries don’t have to come with a hefty price tag. Their strategy echoes the discussions held at events like the National Grocers Association Show, where the focus is on innovative and competitive practices in the grocery sector.

A Community Embraces Affordable, Quality Produce

The community’s response to Raise the Root’s pricing strategy has been overwhelmingly positive. This sentiment is a clear indication of the shifting preferences towards independent grocers, a trend that has been gaining momentum, as seen in the Independent Grocery Store Competition 2021. Shoppers are increasingly looking for stores that offer not just affordability but also a connection to their local community.

The Significance in the Larger Grocery Landscape

Raise the Root’s approach is a significant case study for grocery buying groups and alliances across the country. It highlights how independent stores can leverage their unique position to offer competitive pricing, challenging the dominance of nationwide service grocers. This strategy could very well be a topic of discussion in the next National Grocers Association Member List meeting, as it exemplifies the potential of independent stores in a market dominated by larger chains.

Looking Ahead: The Future of Independent Grocery Stores

As we look towards the future, it’s clear that stores like Raise the Root are setting a new standard for the best independent grocery stores. Their success is a testament to the progressive grocery independents movement, which champions quality, affordability, and community engagement.

Raise the Root’s story is not just about competitive pricing; it’s about the power of local businesses to make a significant impact in their communities. It serves as a reminder that supporting local is not just a choice but an investment in the fabric of our neighborhoods. As we continue to witness the evolution of the grocery industry, it’s evident that independent grocers are not just surviving; they are thriving, offering a personalized, community-focused alternative to the impersonal experience of shopping at larger chains.

In conclusion, the story of Raise the Root in Leslieville is more than just a tale of David and Goliath in the grocery world. It’s a narrative that resonates with the ethos of the Independent Grocers of America and the broader movement towards supporting local, sustainable, and community-oriented businesses. As Raise the Root continues to challenge the status quo, they not only offer a lesson in competitive pricing but also in the power of community and the enduring spirit of independent businesses.

Dr. Reddy’s Laboratories Ltd., a prominent player in the pharmaceutical industry, has recently announced its acquisition of MenoLabs®, a renowned brand in the women’s health and dietary supplements sector. This strategic move was part of Amyris, Inc.’s Chapter 11 sales process.

The acquisition marks a significant expansion for Dr. Reddy’s into the women’s health arena, bringing under its umbrella the entire range of MenoLabs supplements. This portfolio includes seven distinct products, each designed to support women’s health, particularly targeting perimenopause and menopause symptoms. The range features innovative products like MenoFit™ and MenoGlow™ probiotics, Happy Fiber™, Well Rested™ dietary supplements, Athena’s Shield™ for menopause support, and the Goodness Glow™ and Keep Glowing Gorgeous™ supplements, aimed at promoting healthy aging.

An integral part of this acquisition is the MenoLife® health tracker app, which complements the product line by offering a platform for community engagement, educational resources, and menopause-related information. The MenoLabs products have a strong presence in the United States, primarily sold through their website [https://menolabs.com] and other major e-commerce platforms, including Amazon and Walmart.

Marc Kikuchi, CEO of Dr. Reddy’s North America, expressed enthusiasm about the acquisition, stating, “The MenoLabs acquisition is a pivotal step in our journey to become leaders in the rapidly growing women’s nutritional and wellness markets. This addition aligns perfectly with our U.S. self-care and wellness business, offering scientifically backed, research-driven products that address the unmet needs of women experiencing menopause symptoms. We are confident that this acquisition will not only complement our existing portfolio but also drive growth and integration within this business segment.”

This move by Dr. Reddy’s Laboratories Ltd. is seen as a strategic effort to strengthen its position in the women’s health and wellness market, offering a comprehensive range of products backed by scientific research and tailored to meet the specific health needs of women.

In a strategic move aligning with its mission of promoting global health and safety, NSF International has announced the addition of two influential figures to its Board of Directors. Dean Bergy and Nancy Lurker, both celebrated for their extensive leadership in the life sciences industry, join NSF as it commemorates its 80th anniversary. This development was enthusiastically shared by NSF’s President and CEO, Pedro Sancha, underscoring the duo’s potential to significantly contribute to NSF’s ongoing commitment to enhancing human and planetary health.

Dean Bergy: A Blend of Financial Acumen and Health Sector Expertise

Dean Bergy’s illustrious career spans over 25 years at Stryker Corporation, a leader in medical technology. His tenure as Chief Financial Officer and Corporate Secretary, coupled with his status as a Certified Public Accountant, equips him with a unique blend of financial expertise and health sector insight. Bergy’s role in various committees, including the City of Kalamazoo’s Retirement Investment Committee and the Kalamazoo Institute of Arts Endowment Committee, further highlights his diverse skill set. His educational background, featuring a stint at Harvard Business School and a BBA from the University of Michigan, adds to his impressive profile.

Bergy’s perspective on the evolving demands for transparency and responsibility in business aligns seamlessly with NSF’s ethos. His anticipation to contribute to NSF’s critical role in setting and upholding standards across key industries reflects a forward-thinking approach to global health and safety.

Nancy Lurker: A Trailblazer in Pharmaceuticals and Biotechnology

Nancy Lurker’s appointment brings a wealth of experience from her time in leadership roles across the pharmaceutical and biotechnology sectors, including her recent position as CEO of EyePoint Pharmaceuticals Corporation. Her board memberships at EyePoint Pharmaceuticals Corporation and Altasciences, LLC, and advisory roles at Stanford School of Medicine and Novo Holdings, demonstrate her expansive influence in the field. Lurker’s academic credentials, an MBA from the University of Evansville and a Bachelor’s in Biology from Seattle Pacific University, further underscore her expertise.

Lurker’s acknowledgment of NSF’s pivotal role in independent testing and certification, and her commitment to advancing NSF’s mission of protecting health, resonate with the organization’s core values. Her pride in joining NSF’s Board is a testament to the organization’s impactful work.

A Strategic Enhancement for NSF’s Board

The addition of Bergy and Lurker to the NSF Board of Directors is more than just an expansion; it’s a strategic enhancement. Their combined experience and leadership are set to propel NSF’s mission forward, particularly in this landmark 80th year. For more insights and updates on NSF’s initiatives and its impact on global health and safety, stay tuned to IHRMAGAZINE.COM.

The Hain Celestial Group (Nasdaq: HAIN), a leader in the global health and wellness industry, proudly announces a significant achievement in corporate governance. Board member Celeste A. Clark, Ph.D., has been distinguished as a 2023 NACD Directorship 100 Honoree, a testament to her exemplary leadership and influence in the boardroom.

Celeste A. Clark’s Impact at Hain Celestial
Since joining the Hain Celestial Board in 2017, Dr. Clark has been instrumental in steering the company towards success. Her role as Chair of the Compensation Committee and a member of the Corporate Governance and Nominating Committee has brought invaluable insights and guidance to Hain Celestial. CEO and Board Director Wendy Davidson remarks, “Celeste’s leadership and contributions have been outstanding. Her recognition as a 2023 NACD Directorship 100 Honoree is well-deserved and reflects her commitment to excellence in corporate governance.”

The Significance of the NACD Directorship 100
The NACD Directorship 100 is an annual recognition that honors the most influential directors and governance leaders in the corporate world. These individuals are celebrated for their innovation, courage, and integrity in the boardroom. The selection process, based on peer nominations, evaluates nominees across integrity, mature confidence, informed judgment, and high-performance standards. Dr. Clark’s inclusion in this prestigious list underscores her significant contributions to advancing board performance and corporate governance.

Continued Excellence in Corporate Governance at Hain Celestial
Hain Celestial’s commitment to strong board leadership is evident in its members’ achievements. “NACD is renowned for promoting excellence in corporate governance,” Davidson adds. “With Celeste Clark and Dawn Zier, our Board Chair who was named to the NACD 100 in 2022, our board’s strength is paramount to Hain’s ongoing transformation and growth.”

Celeste A. Clark’s recognition as a 2023 NACD Directorship 100 Honoree highlights the caliber of leadership and governance at Hain Celestial. Her achievements reflect the company’s dedication to excellence in corporate governance and its commitment to inspiring healthier living through its products and practices. As Hain Celestial continues to evolve and grow, the strength and expertise of its board members like Dr. Clark play a crucial role in guiding its future success.

Terran Biosciences, a pioneering force in the psychedelic therapeutic space, has recently achieved a significant milestone. The United States Patent and Trademark Office (USPTO) has granted notice of allowance for four US patents under Terran’s banner. These patents are not just a testament to Terran’s innovative approach but also mark a new era in psychedelic therapy, covering new forms of psilocybin, orally active DMT, 5-MeO-DMT, and novel ibogaine derivatives.

New Forms of Psilocybin: A Leap Forward in Neurological and Psychiatric Treatment
Two of Terran’s patents are particularly noteworthy as they cover the world’s first new forms of psilocybin – psilocybin HCl and psilocybin edisylate. These new forms, along with their methods of use, are poised to revolutionize the treatment of neurological and psychiatric disorders, including depression. Historically, clinical trials of psilocybin have been limited to older forms of the compound. Terran’s breakthroughs promise to expand the horizons of psilocybin therapy significantly.

Moreover, Terran is strategically positioned to pursue a rapid 505(b)(2) FDA approval pathway for its new psilocybin forms. This pathway could be a game-changer, allowing Terran to use pharmacokinetic bridging studies and existing safety and efficacy data to expedite the process of bringing a Terran psilocybin product to market.

Orally Active DMT and 5-MeO-DMT: Simplifying Administration
Another groundbreaking achievement by Terran is the development of the world’s first orally active prodrugs of DMT and 5-MeO-DMT. Traditionally, DMT requires combination with a monoamine oxidase inhibitor (MAOI) for oral activity, a method fraught with side effects like nausea and blood pressure changes. Terran’s new prodrugs circumvent these challenges, offering a single oral dose option without the need for an MAOI.

Novel Ibogaine Derivative: Tabernanthalog Monofumarate
Terran’s innovation extends to the development of ibogaine derivatives. The company has received a notice of allowance for a novel form of tabernanthalog monofumarate, which shows promise in treating neurological and psychiatric disorders. This discovery could represent the most stable form of tabernanthalog monofumarate to date.

Terran Biosciences is not just innovating; it’s redefining the landscape of psychedelic therapeutics. With these new patents, Terran is poised to offer more effective, accessible, and convenient treatment options for patients suffering from various neurological and psychiatric disorders. The future of psychedelic therapy is bright, and Terran Biosciences is leading the charge.

SunOpta Inc. (Nasdaq:STKL) (TSX:SOY), a leading name in the sustainable, plant-based food and beverage industry, has today made a significant announcement regarding its leadership. Joseph D. Ennen, who has been at the helm as the Chief Executive Officer for the past five years, is set to retire. His tenure will be remembered for his remarkable contribution to the company’s growth and stability. In his place, the Board has confidently appointed Brian W. Kocher as the new CEO, effective January 2, 2024.

Brian W. Kocher, a seasoned leader in the food industry, is known for his expertise in managing manufacturing-intensive businesses in complex, multinational environments. His previous roles include serving as President and CEO of Calavo Growers Inc. and Castellini Group of Companies, as well as an interim CEO position at Chiquita. His track record in driving growth and operational productivity is expected to be a significant asset to SunOpta as it navigates its next phase of expansion.

The transition is planned to be seamless, with Ennen continuing as an advisor to both the Board and Mr. Kocher until April 1, 2024. This strategy is designed to align with the best interests of all stakeholders involved.

Dean Hollis, Chair of SunOpta’s Board, expressed his gratitude towards Mr. Ennen for his visionary leadership, which has been instrumental in transforming SunOpta’s portfolio and strengthening its financial foundation. This transformation has positioned SunOpta to leverage future growth opportunities effectively.

Joseph D. Ennen reflected on his tenure with pride, especially highlighting the team’s dedication and the company’s steady growth in volume, revenue, and Adjusted EBITDA. He expressed confidence in Brian Kocher’s capabilities to lead SunOpta, emphasizing his deep industry knowledge and commitment to the company’s mission.

Brian W. Kocher expressed his enthusiasm about leading SunOpta into its new chapter, acknowledging the strong foundation laid by his predecessor. He looks forward to advancing the company’s mission of fueling the future of food, building on the existing momentum.

Brian W. Kocher’s Background:

Brian W. Kocher’s impressive career spans various leadership roles. Before his tenure at Calavo Growers Inc., he led the Castellini Group of Companies and held significant positions at Chiquita Brands International, Inc. He is an alumnus of Ohio University, holding a Bachelor of Business Administration in Accounting.

This leadership change marks a pivotal moment for SunOpta, as it continues to champion the cause of sustainable and plant-based food solutions. Stakeholders and industry watchers alike are keen to see how Brian W. Kocher’s vision and strategy will steer SunOpta towards new horizons of success and innovation.